路透社纽约12月29日健康新闻，芬兰的研究院在《过敏症》12月刊报道，母亲先前服用口服避孕药丸（OCPs）会影响后代发生过敏性鼻炎的危险。
芬兰库奥皮奥大学的Leea Keshi-Nisula博士和他的同伴解释道，这就暗示口服避孕药和过敏性疾病存在联系。
为了调查这是否对于特定的OPC成分有特异性的关系，研究者对618名5或6岁患有哮喘的儿童和564名对照儿童进行了研究。
该小组发现，与以前母亲未服用OCPs的孩子相比，母亲在1年孕期内服用过妈富隆、孕二烯酮或孕激素三种之一与乙炔雌二醇联合使用的儿童，患有过敏性鼻炎的危险明显增加（优势比，1.67）。
这种情况在亲代患有过敏性疾病的病例中更为显著（优势比，1.78），而而这种联系在男孩中表现更强（优势比，2.12）。
而母亲是否使用OPCs似乎对于哮喘或特应性湿疹没有影响。
研究人员解释道，服用更多促雄性性状的黄体酮的母亲在早期怀孕时血清孕酮的水平更高。
因此，研究者得出结论：这个结果是“实验性质的并且可能是令人兴奋的”，而且他们表示对于OPCs和黄体酮类型与过敏关系的研究可能是很有价值的。
Oral Contraceptives Tied to Allergy Risk in Children
NEW YORK (Reuters Health) Dec 29 - Previous maternal use of oral contraceptive pills (OCPs) appears to influence the risk of allergic rhinitis in subsequent offspring, Finnish researchers report in the December issue of Allergy.
Dr. Leea Keski-Nisula, of Kuopio University, Finland, and colleagues note that there has been a suggestion of an association between OCP use and allergic diseases.
To investigate whether thus might be particularly so for specific OCP formulations, the researchers studied 618 asthmatic children aged 5 or 6 years and 564 controls.
The team found that, compared to children whose mothers had not used OCPs, maternal use of desogestrel, gestodene or cyproterone acetate each combined with ethinylestradiol, within 1 year of pregnancy, increased the risk of allergic rhinitis among offspring (odds ratio, 1.67).
This was particularly the case in families with parental allergy (odds ratio. 1.78) and this association was stronger in boys (odds ratio, 2.12).
No association with asthma or atopic eczema was seen in offspring of mothers who had used OCPs.
The researchers note that women who had used more androgenic types of progestin formulas had higher serum levels of progesterone during early pregnancy.
The results are "tentative and possibly provocative" and they suggest that an allergy study of OCPs and of the type of progestin, may be of value, the investigators conclude.
Allergy 2006;61:1467-1472.
http://www.medscape.com/viewarticle/550058
编辑：蓝色幻想
